Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., . . . Papakostas, G. I. (2020). Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular psychiatry, 25(7), 1592-1603. https://doi.org/10.1038/s41380-018-0256-5
Citácia podle Chicago (17th ed.)Fava, Maurizio, et al. "Double-blind, Placebo-controlled, Dose-ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-resistant Depression (TRD)." Molecular Psychiatry 25, no. 7 (2020): 1592-1603. https://doi.org/10.1038/s41380-018-0256-5.
Citácia podľa MLA (8th ed.)Fava, Maurizio, et al. "Double-blind, Placebo-controlled, Dose-ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-resistant Depression (TRD)." Molecular Psychiatry, vol. 25, no. 7, 2020, pp. 1592-1603, https://doi.org/10.1038/s41380-018-0256-5.